<p>The human nervous system-that most complex organization of energy and matter-has yielded a few glimmers of understanding of its operational meΒ chanics during the last two decades. These have mostly been at the biochemical level of structure and function. Throughout history, as one of the mysteri
MOVEMENT DISORDERS 4
β Scribed by Anthony H.V. Schapira, Anthony E.T. Lang and Stanley Fahn (Eds.)
- Publisher
- Saunders
- Year
- 2010
- Tongue
- English
- Leaves
- 476
- Series
- Blue Books of Neurology 34
- Edition
- 1
- Category
- Library
No coin nor oath required. For personal study only.
β¦ Synopsis
Multiple Sclerosis 3 emphasizes the latest in the pharmacologic treatment of this incurable inflammatory demyelinating disorder. Primary editors Claudia Lucchinetti, MD, and Reinhard Hohlfeld, MD, with the aid of all new contributors, present a complete and current reference on multiple sclerosis that includes discussions of such hot topics as Biomarkers, Genomics, and Surrogate Outcomes in MS; Pediatric MS; Transverse Myelitis; Attack Therapies in MS; Current Disease-Modifying Therapeutic Strategies in MS; Management of Aggressive MS; Symptomatic Therapies in MS; Complementary and Alternative Medical Therapies; and Strategies to Promote Neuroprotection and Repair. Distinguish between MS and other similar demyelinating disorders and know the best and most aggressive methods of treatment. This title in the Blue Books of Neurology series is exactly what you need to treat the disease and its relapses.Covers the latest clinical advances and relevant discussions-Biomarkers, Genomics, and Surrogate Outcomes in MS; Pediatric MS; Transverse Myelitis; Attack Therapies in MS; Current Disease-Modifying Therapeutic Strategies in MS; Management of Aggressive MS; Symptomatic Therapies in MS; Complementary and Alternative Medical Therapies; and Strategies to Promote Neuroprotection and Repair-to bring you up to date and keep your practice state-of-the-art.Features a greater emphasis on practical management to help you determine the type of multiple sclerosis and the best course of therapy.Focuses on pharmaceutical therapies so you know the best and most aggressive methods and which drugs to use for treatment.Includes extensive information on differential diagnosis so that you can clearly distinguish between multiple sclerosis and other similar demyelinating disorders.Presents expert new editors and experienced contributing authors for the most current and relevant practice information.Emphasizes the pharmacologic management of patients with multiple sclerosis to address treating the actual disease and its relapses as well as treating the symptoms.
β¦ Table of Contents
Content:
Copyright
Page iv
BLUE BOOKS OF NEUROLOGY
Pages v-vii
CONTRIBUTING AUTHORS
Pages xiii-xxii
Kailash Bhatia, Vincenzo Bonifati, David James Brooks, Jonathan M. Brotchie, David John Burn, Yaroslau Compta, Ted M. Dawson, Gunther Deuschl, Dennis W. Dickson, Stanley Fahn, Matthew James Farrer, Alfonso Fasano, Alessandro Ferraris, Susan Fox, Carles Gaig, Thomas Gasser, Felix Geser, Amitabh Gupta, Glenda Halliday, Clement Hamani, et al.
SERIES PREFACE
Page xxiii
Anthony H.V. Schapira, Martin A. Samuels
PREFACE
Page xxv
Anthony schapira, Anthony Lang, Stanley Fahn
Chapter 1 - Functional Anatomy and Pathophysiology of the Basal Ganglia
Pages 1-13
Jonathan M. Brotchie, JosΓ© A. Obeso
Chapter 2 - Genetics of Parkinson's DiseaseβAn Overview
Pages 15-39
Christine Klein
Chapter 3 - Ξ±-Synuclein and Parkinson's Disease
Pages 40-53
Thomas Gasser
Chapter 4 - PARK2: Parkin Mutations Responsible for Familial Parkinson's Disease
Pages 54-65
Nobutaka Hattori, taku Hatano, Yutaka Machida, Shigeto Sato, Shin-Ichiro Kubo
Chapter 5 - PINK1 (PARK6) and Parkinson's Disease
Pages 66-82
Enza Maria valente, Alessandro Ferraris
Chapter 6 - DJ-1 (PARK7) and Parkinson's Disease
Pages 83-101
Vincenzo Bonifati
Chapter 7 - LRRK2 and Parkinson's Disease
Pages 102-112
Matthew James Farrer
Chapter 8 - Environmental Factors and Parkinson's Disease
Pages 113-131
Caroline M. Tanner
Chapter 9 - Pathology of Parkinson's Disease
Pages 132-154
Glenda Halliday, Karen Murphy
Chapter 10 - Pathogenesis of Parkinson's Disease
Pages 155-169
Amitabh Gupta, Ted M. Dawson
Chapter 11 - Imaging in Parkinson's Disease
Pages 170-187
David James Brooks
Chapter 12 - Dementia in Parkinson's Disease
Pages 188-212
David John Burn
Chapter 13 - Psychiatric Issues in Parkinson's Disease
Pages 213-228
Daniel Weintraub
Chapter 14 - Nonmotor Aspects of Parkinson's Disease
Pages 229-251
Eduardo Tolosa, Joan Santamaria, Carles Gaig, Yaroslau Compta
Chapter 15 - Therapy of the Motor Features of Parkinson's Disease
Pages 252-272
Susan Fox, Anthony E. Lang
Chapter 16 - Surgical Therapy for Parkinson's Disease
Pages 273-286
Adrian W. Laxton, Clement Hamani, Andres M. Lozano
Chapter 17 - Cell-Based and Gene-Based Therapy for Parkinson's Disease
Pages 287-300
C. Warren Olanow
Chapter 18 - Neuroprotection in Parkinson's Disease
Pages 301-320
Anthony H.V. Schapira
Chapter 19 - Etiology, Pathology, and Pathogenesis
Pages 321-339
Felix Geser, Kurt Jellinger, Martin KΓΆllensperger, Nadia Stefanova, Gregor K. Wenning
Chapter 20 - Multiple System Atrophy: Clinical Features and Management
Pages 340-359
Werner Poewe, Klaus Seppi
Chapter 21 - Progressive Supranuclear Palsy
Pages 361-374
Huw R. Morris
Chapter 22 - Corticobasal Ganglionic Degeneration
Pages 375-396
Keith A. Josephs
Chapter 23 - Frontotemporal Dementia
Pages 397-416
Christian W. Wider, Dennis W. Dickson, Rosa Rademakers, Zbigniew K. Wszolek
Chapter 24 - Etiology, Pathology, and Pathogenesis
Pages 417-431
Patrick Weydt, G. Bernhard Landwehrmeyer, Albert C. Ludolph
Chapter 25 - Clinical Features and Care
Pages 432-456
Ira Shoulson
Chapter 26 - The Genetics and Pathogenesis of Dystonia
Pages 457-473
Thomas T. Warner
Chapter 27 - Management
Pages 474-488
Elena Moro, Marie Vidailhet
Chapter 28 - Paroxysmal Dyskinesias
Pages 489-505
Kailash P. Bhatia, Susanne A. Schneider
Chapter 29 - Essential Tremor and Other Tremors
Pages 506-557
GΓΌnther Deuschl, Alfonso Fasano
Chapter 30 - Other Choreas
Pages 558-586
Ruth H. Walker
Chapter 31 - Restless Legs Syndrome
Pages 587-621
Wayne Hening, Claudia Trenkwalder
Chapter 32 - Startled People
Pages 622-629
Philip Thompson
Chapter 33 - Psychogenic Movement Disorders
Pages 630-650
Madhavi Thomas, Joseph Jankovic
Chapter 34 - Tics and Gilles de la Tourette Syndrome
Pages 651-663
Harvey S. Singer
Index
Pages 665-684
π SIMILAR VOLUMES
Praise for the First Edition:β"This instructive text will serve as a reference for specialists in the care of patients with these disorders and for general neurologists and others to whom a patient with Stiff-Person syndrome or Wilson's disease is a rarity. The emphasis on the neuroscientific basis
Part of the "What Do I Do Now?" series,<em> Movement Disorders</em> uses a case-based approach to cover common and important topics in the examination, investigation, and management of Parkinson's disease, gait disorders, dystonia, and other movement disorders. Each chapter provides a discussion of
This book provides insights into the meaningful milestones of leaders and world experts in the field of movement disorders/neurology. Through the format of interview questions, it communicates the skills of key leaders in movement disorders. The interviewees are past and present leaders of the Inter
Movement Disorders 1994-07: <a href="https://archive.org/search.php?query=sim_pubid%3A18729%20AND%20volume%3A9" rel="nofollow">Volume 9</a>, Issue 4.<br />Digitized from <a href="https://archive.org/details/sim_raw_scan_IA1643512-03/page/n56" rel="nofollow">IA1643512-03</a>.<br />Previous issue: <a
Eye Movement Disorders, by Dr. Agnes Wong, fills a great void in the Ophthalmology and Neurology literature by presenting eye movement disorders in a full-color, highly illustrative format. This text explains eye movement disorders in a concise yet comprehensive manner, which makes it an excellent